NYXH Share Price Performance

NYXH Community Fair Values

AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
FDA Approval Will Launch Genio And Expand Global Reach
Key Takeaways Imminent FDA approval of Genio could significantly boost revenues and market penetration in the U.S., driven by robust clinical results and strategic recruitment. Expansion into international markets and strategic use of reimbursement codes are expected to enhance revenue growth, market diversification, and margin stability.
€12.22
FV
46.6% undervalued intrinsic discount
195.80%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
3 months ago author updated this narrative

View all narratives

Recent NYXH News & Updates

No updates

Nyxoah SA Key Details

Last Reported Earnings

Mar 31, 2025

Next Reporting Earnings

Aug 18, 2025

Earnings per share (EPS): -1.86
Gross Margin: 65.56%
Net Profit Margin: -1,597.48%
Debt/Equity Ratio: 20.2%

View full report ›

Nyxoah SA Competitors

View more competitors

About NYXH

Founded: 2009
Employees: 184
CEO: Olivier Taelman
WebsiteView website: www.nyxoah.com

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Belgian Market Performance

7 Days: -3.9%
3 Months: -0.7%
1 Year: 3.2%
Year to Date: 4.9%

Over the last 7 days, the market has dropped 3.9%, driven by a decline of 14% in the Consumer Staples sector. In contrast, the Healthcare sector has actually gained 8.4%. As for the longer term, the market has actually risen by 3.2% in the last year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›

💥 How Agentic AI Could Change Every Industry

Richard Bowman

August 2025

This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.

Last Week

Nyxoah Stock Price